Related Experiment Video
Updated: Aug 14, 2026
11:22
The α-test: Rapid Cell-free CD4 Enumeration Using Whole Saliva
Published on: May 16, 2012
[CBO guidelines 'Antiretroviral therapy in the Netherlands']
J C Borleffs1, S A Danner, J M Lange
1Universitair Medisch Centrum, afd. Interne Geneeskunde, onderafd. Infectieziekten en Aids, Postbus 85.500, 3508 GA Utrecht. j.c.c.borleffs@azu.nl
Nederlands Tijdschrift Voor Geneeskunde
|September 6, 2001
Summary
New guidelines recommend starting antiretroviral treatment for HIV-infected adults with viral load > 30,000 copies/ml or CD4+ count < 350 cells/µL. For children, treatment is advised if viral load > 5,000 copies/ml.
Area of Science:
- Infectious Diseases
- Virology
- Public Health
Context:
- Updated guidelines for HIV diagnosis and treatment in the Netherlands.
- Incorporates recent scientific developments and recommendations from the Dutch Institute for Health Care Improvement (CBO).
Purpose:
- To outline current recommendations for the diagnosis and treatment of Human Immunodeficiency Virus (HIV) infection.
- To provide clear criteria for initiating antiretroviral therapy (ART) in adults and children.
- To detail optimal ART regimens, monitoring schedules, and strategies for preventing mother-to-child transmission and opportunistic infections.
Summary:
- ART initiation in adults is recommended if HIV viral load exceeds 30,000 RNA copies/mL or CD4+ cell count falls below 350 cells/µL.
- ART in children is indicated for HIV viral load > 5,000 copies/mL, irrespective of CD4+ count.
- Optimal ART involves a combination of two nucleoside reverse transcriptase inhibitors (NRTIs) plus either a protease inhibitor or a non-nucleoside reverse transcriptase inhibitor.
- Monitoring ART efficacy every 3 months with the goal of achieving an undetectable HIV viral load is crucial.
- Antiretroviral drugs are recommended after the first trimester for pregnant women with detectable HIV to prevent mother-to-child transmission.
- Prophylaxis for opportunistic infections can cease when CD4+ cell count consistently exceeds 200 cells/µL.
- Post-exposure prophylaxis (PEP) is advised following potential HIV exposure after risk assessment.
- Vaccinations against pneumococci, influenza, hepatitis A, and hepatitis B are recommended when CD4+ cell count is above 200 cells/µL.
Impact:
- Provides evidence-based guidance for clinicians managing HIV patients.
- Aims to improve patient outcomes by optimizing treatment initiation and regimens.
- Contributes to reducing HIV transmission rates and managing opportunistic infections effectively.
- Supports public health efforts in controlling the HIV epidemic.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...